Biotech Founder Vivek Ramaswamy Enters GOP Presidential Race

Norge Nyheter Nyheter

Biotech Founder Vivek Ramaswamy Enters GOP Presidential Race
Norge Siste Nytt,Norge Overskrifter
  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Multimillionaire biotech company founder and investor Vivek Ramaswamy said he is entering the 2024 Republican presidential nomination race

Vivek Ramaswamy says the nation faces an identity crisis over what it stands for and where it needs to go.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

WSJ /  🏆 98. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Vivek Ramaswamy ramps up presidential buzz, lays out vision for the country with imminent 2024 decisionVivek Ramaswamy ramps up presidential buzz, lays out vision for the country with imminent 2024 decisionIn a wide-ranging interview with Fox News Digital, entrepreneur and author Vivek Ramaswamy offered how the next president should tackle the issues facing the United States today.
Les mer »

'Woke, Inc.' author Vivek Ramaswamy enters 2024 presidential election'Woke, Inc.' author Vivek Ramaswamy enters 2024 presidential electionNEW: Venture capitalist Vivek Ramaswamy, the author of the book 'Woke Inc.,' announced on Tucker Carlson’s Fox News show on Tuesday that he's running for president.
Les mer »

Conservative entrepreneur and 'anti-woke' crusader Vivek Ramaswamy launches GOP presidential campaignConservative entrepreneur and 'anti-woke' crusader Vivek Ramaswamy launches GOP presidential campaignVivek Ramaswamy, a health care and tech sector entrepreneur, conservative commentator and author who’s become a crusader in the culture wars, declared his candidacy for president
Les mer »

Biotech Azitra files for IPO with ThinkEquity acting as sole underwriterBiotech Azitra files for IPO with ThinkEquity acting as sole underwriterAzitra Inc., a biopharmaceutical company that’s developing treatments for skin diseases, filed for an initial public offering on Tuesday with ThinkEquity...
Les mer »

Genentech expands in Oceanside with $450M biotech manufacturing facility and 150 jobsGenentech expands in Oceanside with $450M biotech manufacturing facility and 150 jobsGenentech is expanding its manufacturing capabilities in Oceanside. The biologics facility is set to open by early 2025.
Les mer »



Render Time: 2025-03-09 08:32:06